We serve Chemical Name:benzyl N,N-diethylcarbamodithioate CAS:3052-61-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:benzyl N,N-diethylcarbamodithioate
CAS.NO:3052-61-7
Synonyms:S-benzyl-N,N-diethyldithiocarbamate;Benzyl diethyldithiocarbamate;Diethyldithiocarbamic Acid Benzyl Ester;benzyl diethylcarbamodithioate;benzyl N,N-diethyldithiocarbamate;N,N-diethyl S-benzyl dithiocarbamate;SNBMGLUIIGFNFE-UHFFFAOYSA
Molecular Formula:C12H17NS2
Molecular Weight:239.40000
HS Code:2930909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:172ºC / 15mmHg
Density:1.12
Index of Refraction:1.599
PSA:60.63000
Exact Mass:239.08000
LogP:3.54650
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like S-benzyl-N,N-diethyldithiocarbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,SNBMGLUIIGFNFE-UHFFFAOYSA physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,N-diethyl S-benzyl dithiocarbamate Use and application,N,N-diethyl S-benzyl dithiocarbamate technical grade,usp/ep/jp grade.
Related News: Fate Therapeutics�� iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications. benzyl N,N-diethylcarbamodithioate manufacturer Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections. benzyl N,N-diethylcarbamodithioate supplier Fate Therapeutics�� iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications. benzyl N,N-diethylcarbamodithioate vendor Fate Therapeutics�� iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications. benzyl N,N-diethylcarbamodithioate factory In that group, the vaccine slowed brain decline by around 30% in two different clinical and functional tests, Novak said.
